Phase
Condition
Obesity
Diabetes (Pediatric)
Diabetes And Hypertension
Treatment
Mango
Placebo
Clinical Study ID
Ages 50-70 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Free of any chronic diseases such as cancer
BMI of 18.5 kg/m2 to 34.9 kg/m2
wHbA1c values are 100 mg/dl to 125 mg/dl and HbA1C of 5.7-6.4 %
Exclusion
Exclusion Criteria:
Individuals diagnosed with cardiovascular diseases (CVD), type 2-diabetes, type 1diabetes mellitus, other active chronic diseases such as cancer, asthma, glaucoma,kidney, liver and pancreatic disease
Uncontrolled hypertension (≥160/100 mmHg)
BMI <18.5 kg/m2 or >34.9 kg/m2
Not post-menopausal or have been taking hormone replacement therapy for less than 3months
taking more than one anti-hypertensive or have been taking them for less than 3months
Participating in a weight loss program or having lost or gain ≥10% bodyweight withinthe last 6 months
Smoke more than 1 pack/day
Consumption of >12 alcoholic drinks/week
Frequent mango consumers (>5 servings/2weeks)
In concurrent participation with another investigational study
Currently consuming any performance supplement (i.e. creatine, nitric oxide,whey/casein protein, branched chain amino acids).
None of the following special populations will be included: adults unable toconsent, individuals who are not yet adults (infants, children, teenagers),pregnant women, or prisoners.
Study Design
Study Description
Connect with a study center
Florida State University
Tallahassee, Florida 32306
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.